Methyl oleanonate

CAS No. 1721-58-0

Methyl oleanonate( 3-Oxoolean-12-en-28-oic acid methyl ester | Methyl oleanonate )

Catalog No. M29448 CAS No. 1721-58-0

3-Oxoolean-12-en-28-oic acid methyl ester is a triterpenoid PPARγ agonist isolated from Pistacia with anticancer properties.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
2MG 140 Get Quote
5MG 236 Get Quote
10MG 350 Get Quote
25MG 578 Get Quote
50MG 795 Get Quote
100MG Get Quote Get Quote
200MG Get Quote Get Quote
500MG Get Quote Get Quote
1G Get Quote Get Quote

Biological Information

  • Product Name
    Methyl oleanonate
  • Note
    Research use only, not for human use.
  • Brief Description
    3-Oxoolean-12-en-28-oic acid methyl ester is a triterpenoid PPARγ agonist isolated from Pistacia with anticancer properties.
  • Description
    3-Oxoolean-12-en-28-oic acid methyl ester is a triterpenoid PPARγ agonist isolated from Pistacia with anticancer properties.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    3-Oxoolean-12-en-28-oic acid methyl ester | Methyl oleanonate
  • Pathway
    Metabolic Enzyme/Protease
  • Target
    PPAR
  • Recptor
    PPAR
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    1721-58-0
  • Formula Weight
    468.71
  • Molecular Formula
    C31H48O3
  • Purity
    >98% (HPLC)
  • Solubility
    In Vitro:?DMSO : 2.5 mg/mL (5.33 mM)
  • SMILES
    CC1(C)C(CC[C@]2(C)[C@@]3([H])CC=C4[C@]5([H])CC(C)(C)CC[C@@](C(OC)=O)5CC[C@](C)4[C@@](C)3CC[C@@]12[H])=O
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • AZD2461

    AZD2461 is a novel PARP inhibitor.

  • T0070907

    T0070907 is a potent and selective PPARγ inhibitor with IC50 of 1 nM.

  • Alliin

    Alliin is a garlic organosulfur compound that possesses various pharmacological properties.alliin protected against LPS-induced ALI by activating PPARγ which subsequently inhibited LPS-induced NF-κB activation and inflammatory response.?